| |
 |
 |
|
|
 |
|
Pharmacodynamic
and Pharmacology Research |
OsteoKing
has been granted China National Approval Certificate
in year 2002 by completing all the very strict
researches and tests according to China nation
standards. It has been proven by clinical applications
that OsteoKing has remarkable effectiveness and
very safe in treating bone diseases, especially
for femoral head necrosis, prolapse of lumbar
intervertebral disc, osteoarthritis, osteoporosis
and fractures.
In order to explore its mechanism
of the therapeutic effects, the company has taken
the lead and completed the researches in foremost
level of biochemistry, histomorphology, molecular
biology for OsteoKing. The research results show
that OsteoKing can reduce blood viscosity, improve
hemodynamics, reduce internal pressure of bone,
improve blood supply, reduce blood fat concentration,
reduce the formation of fat embolism and promote
the genetic expression of endogenous VEGF(Vascular
endothelial growth factor), cbf ?1(core binding
factor ?1) and BMP-2(Bone morphogenetic proteins-2).
It can also strengthen the activity of bone cells,
inhibit osteoclast cells and promote the repair
of bone.
OsteoKing has solved the core
problems of bone disease by decreasing blood fat,
anti-coagulation, fibrinolysis and anti-inflammation
so that patients can speed up their recoveries
effectively. OsteoKing provides scientific evidence
for non-surgery treatment for bone diseases and
fractures and it is the best solution for clinical
treatment. It has been listed as the research
project founded by China National Natural Science.
The results of pharmacodynamic show that OsteoKing
has the following functions:
Anti-inflammation and detumescence |
Effective Pain Relief |
Inhibiting thrombosis, improving blood circulation
and microcirculation. |
Activating the cells of periost osteogenesis,
promoting the formation of new bone cells
and the repair of necrotic bone. |
Promoting the regeneration and matureness
of bone trabecula and increasing the bone
density |
Decreasing blood fat, anti-coagulation, and
fibrinolysis |
Preventing the deep vein thrombosis (DVT)
after bone diseases operation and protecting
and repairing the venous endothelial cell
injured by mechanical force. |
Promoting the formation of blood vessel by
promoting the genetic expression of endogenous
VEGF, effectively improve the activity of
osteoblasts and speed the formation of bone
cells. |
Promoting the development, differentiation,
regulation of osteoblasts and bone calcification
by boosting the genetic of cbf ?1. |
Inducting ossification and stimulating the
formation of bone cells by boosting the genetic
of BMP-2. |
Femoral head necrosis is a
difficult and complex bone disease. In recent
years, femoral head necrosis has become the key
problem that medical experts in the world are
working on. After extensive studies done by medical
experts worldwide on the mechanism of necrosis
of femoral head, the results point out that the
principle for treating necrosis of femoral head
is to decrease blood fat, anti-coagulation, fibrinolysis
and anti-inflammation. Those concepts have now
been widely accepted by the medical field.
Based on the above principle, western medicine
uses compound medicines to treat necrosis of femoral
head. Long term usage of them has caused lots
of side effects to patients and also high treatment
costs but the effectiveness is not long lasting.
Therefore non-operation treatment by using herbs
is becoming the new focus all over the world.
A large of clinical research have approved that
OsteoKing is the unique herbal medicine with practical
value. It is one product, but has four functions
of decreasing blood fat, anti-coagulation, fibrinolysis
and anti-inflammation, which solves the core problems
of bone diseases - blood supply and thrombosis.
It is one of the very unique herb products.
OsteoKing not only has unique and remarkable curative
effects to femoral head necrosis, but also to
prolapse of lumbar intervertebral disc, osteoarthritis,
osteoporosis and fractures. OsteoKing greatly
reduces the disable rate and facilitates the patient’s
early recovery.
The researches on the functions:
Anti-inflammation and detumescence
Test: OsteoKing was applied to rat metatarsal
swelling caused by egg whites.
The results showed that the product significantly
inhibits rat metatarsal swelling. (compared with
control group, p <0.05)
Test: OsteoKing was applied to mice injected 0.7%
acetic acid into their abdomen cavities.
The results indicated that OsteoKing possesses
significant property in inhibiting the raising
of capillary permeability of mice caused by injected
acetic acid into their abdominal cavities. (compared
with control group, p<0.01)
Pain Relief
OsteoKing was applied to mice whose pain threshold
stimulated by a hot plate. The results indicate
that the product can relieve the pain caused by
a hot plate. (compared with control group, p<0.05)
OsteoKing was given to a mouse with convulsion
caused by an acetic acid injection into its abdominal
cavity.
The results showed that the product produces a
significant analgesic effect on pain caused by
chemical substances. (compared with control group,
p<0.01)
Inhibiting thrombosis, improving blood circulation
and microcirculation
OsteoKing was given to rats with thrombosis. The
results showed that the product could inhibit
rat thrombosis in vivo and improve blood circulation
and microcirculation. (compared with control group,
p<0.01)
Decreasing blood fat
To perform the test of blood fat of necrotic bone,
rabbits were divided into three groups: no-treatment
control group, model group, and OsteoKing group.
The test measured the serum cholesterol (CHOL)
and triglyceride (TG) and high density lipoprotein
(HDL) and the results were statistically evaluated
by using SPSS 10.0 s software, t examination and
multivariate variance analysis for the enumeration
data. The difference has statistics significance
(compared with control group, p<0.01).
The results showed that necrotic bone is closely
related to disturbance of lipid metabolism. OsteoKing
can decrease the serum cholesterol (CHOL) and
triglyceride (TG) significantly and increase HDL
significantly. OsteoKing possesses significant
function in decreasing blood fat.
Promoting the repair of necrotic bone.
Observation with optical microscope, transmission
electron microscope and
scanning electron microscope, the results showed
|
| The
general observation: |
|
|
|
|
|
No-treatment
control group: normal femoral head |
Model group:
modeling cartilage has become thin; the
bone trabecula has disordered and appeared
oily condition. |
OsteoKing
group: the thickness of cartilage is normal
and fat is little. |
| The
results observed with optical microscope: |
|
|
|
|
|
No-treatment
control group: normal femoral head |
Model group:
the bone trabecula has disordered and
become thinner, sparse. The medullar cavity
is full of empty lipid cells. |
OsteoKing
group: more new bone is formed on the
surface of bone trabecula. |
| The
results observed with transmission electron
microscope: |
|
|
|
|
|
Model group:
necrosis occurred, the medullar cavity
bled, collagen was disturbance |
Model group:
necrosis occurred, the medullar cavity
bled seriously, |
Model group:
bone tissues have become degenerately
necrosis and bleeding |
|
|
|
|
|
OsteoKing
group: new bone trabecula and original
bone trabecula |
OsteoKing
group: more blood capillary appeared |
OsteoKing
group: more osteoblasts and new bone cells
appeared |
| The
results observed with scanning electron
microscope: |
|
|
|
|
|
No-treatment
control group: the normal membranous structure
on the surface of bone trabecula |
Model group:
the membranous structure was destroyed |
OsteoKing
group: the membranous structure was normal
and the formation of bone was active |
|
The
results indicate that OsteoKing can promote the
repair of necrotic bone. Necrotic bone cells are
less in the OsteoKing group, more osteoblasts
and osteoclasts, new bone cells and bone matrix
are appeared as well as calcium deposit occurs.
The results observed with scanning electron microscope
indicate that more osteoblasts appeared on the
surface of bone trabecula. OsteoKing group has
remarkable superiority compares with model group.
Promoting the formation of blood vessel by promoting
the genetic expression of endogenous VEGF, effectively
improve the activity of osteoblasts and speed
the formation of bone cells.
VEGF (Vascular endothelial growth factor) is very
closely related to bone repair and plays a very
important role in the formation and repair of
bone. (Lieberman JR, et al. Instr Course Lect,
2003; 52:337-55. ?Carano RA, et al. Drug Discov
Today. 2003, 8(21): 980-989.?Yancopoulos GD,et
al. Nature. 2000, 407(6801):242-248. Review.)
Tested through the methods of immunohistochemistry,
hybridization in situ, real-time fluorescent fixed
quantity and PCR and verified each other then
draw the same conclusion that OsteoKing can promote
the expression of endogenous VEGF in the necrotic
femoral head and increase the expression volume
significantly. Compared with Model group, the
difference has statistics significance (p<0.05).
Promoting the development, differentiation, regulation
of osteoblasts and bone calcification by boosting
the genetic of cbf ?1.
cbf ?1 (core binding factor ?1) gene is osteogenesis
specificity transcription activation factor, It
plays a very important role during the development
and differentiation of the osteoblast and the
bone formation.(Ducy P, et al. Cell, 1997, 89(5):747~754.?Komori
T, et al. Cell, 1997, 89(5):755-764.?He J, et
al. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod, 2004, 97(2):239-245.)
Tested through the methods of immunohistochemistry,
hybridization in situ, real-time fluorescent fixed
quantity and PCR and verified each other then
draw the same conclusion that OsteoKing can promote
the repair of necrotic bone through promoting
the expression of cbf ?1 in the necrotic femoral
head and increase the expression volume significantly.
Compared with the model group, the difference
has statistics significance (p<0.05).
Inducting ossification and stimulating the formation
of bone cells by boosting the genetic of BMP-2.
BMP-2 (Bone morphogenetic proteins-2) has very
powerful activity in inducting ossification (Wozney
JM, et al. Science, 1988, 242(4885): 1528-1534.?Croteau
S,et al. Orthopedics, 1999, 22(7):686-695.?Shore
EM, et al. Clin Orthop, 1995, (311):199-209.)
Tested through the methods of immunohistochemistry,
hybridization in situ, real-time fluorescent fixed
quantity and PCR and verified each other then
draw the same conclusion that OsteoKing can promote
the repair of necrotic bone through promoting
the expression of BMP-2 in the necrotic femoral
head and increase the expression volume significantly.
Compared with the model group, the difference
has statistics significance (p<0.05).
Promoting healing of fractures
Test of the effect of OsteoKing on fractures:
The radius diaphysis of rabbits was totally fractured
with a double blade saw. The gap between the broken
parts is 3mm.The models were separated into: a
no-treatment control group, a drug-taking group
(taking another bone medicine) and an OsteoKing
group. X-rays were taken, fracture-resistant strength
tests were administered, and a histopathological
examination was done.
The results showed that OsteoKing can promote
the healing of fractures and speed of recovery.
The researches of OsteoKing are performed with
the latest modern methods and receive the scientific
data, from many angles and aspects to analysis
the mechanism of the therapeutic effects of OsteoKing
deeply to the genetic level. Those provide solid
scientific data for the clinical application.
|
The results of pharmacology research showed:
OsteoKing strengthens the function of the
pituitary -- adrenal cortex system, inhibits
the function of hyaluronidase, chrondroitin
enzyme, PG synthetase, 5_HTp and histamine.
All those develop stronger anti-inflammatory
and analgesic effects as well as reduction
of swelling. |
OsteoKing enlarges blood vessels, reduces
peripheral resistance and strengthens general
blood circulation. |
OsteoKing decreases the synthesis of TXA2,
increases the content of cAMP by inhibiting
thrombus alkane A2 (TXA2) synthetase, activates
adenyl cyclase in blood platelets, and inhibits
the function of phosphodiesterase so it
can develop the functions of anti-platelet
aggregation and inhibiting thrombosis. |
OsteoKing activates periost osteoblast,
the growth and reconstruction of callus
tissues, and the formation of new bone cells
that improve the healing of fractures and
promote the repair of femoral head. |
Some ingredients in OsteoKing can block
the path of receptive calcium ions from
blood vessel's smooth muscle, block the
internal flow of Ca2+ and the release of
Ca2+ within cells, and therefore enlarge
the external blood vessels, especially for
the spastic small vessels. These factors
improve microcirculation and the supply
of blood and oxygen to the cells of injured
tissues. |
OsteoKing contains several amino acids,
ossein, and several microelements that play
important roles in the treatment of bone
injuries and diseases, therefore it promotes
the healing of factures and the recovery
of bone diseases. It shortens the period
of treatment.
All these pharmacology functions create
a favorable condition for the recovery of
fractures and bone diseases. |
|
|
 |
|
|
|